Investors and Partnering

Neuro-Bio Ltd welcomes enquiries from individuals, research and commercial organisations wishing to play their part in this ground-breaking approach to diagnosis and treatment of Alzheimer’s disease.

Our activities centre on the pivotal process during neuro-degeneration in Alzheimer’s but we are also keen to exchange ideas on diagnosis and treatment of other neuro-degenerative diseases, perturbations to the blood brain barrier and other forms of aberrant development such as cell migration in cancer. Proprietary antibodies are available for in vitro and potentially in vivo evaluation by third parties.

In the first instance, please contact Julie Peachey, our Business Manager, who will direct your enquiry appropriately. Alternatively please email us at info@neuro-bio.com.